1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Greece Pharmaceuticals and Healthcare Report Q3 2016

Greece Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 84 pages

Includes 3 FREE quarterly updates

BMI View: The government's focus on increasing the consumption of generic medicines and poor financialadministration highlights Greece as a challenging market for innovative drugmakers. Despite an urgentneed to reduce pharmaceutical and healthcare spending, enduring public scepticism of generic medicineswill prevent targeted reduction in patented drug usage. Moreover, dissatisfaction among the public andprofessionals over staff shortages, poor wages and pension reform within the healthcare sector, coupledwith corruption issues and the ongoing migrant influx, signify an unhealthy outlook.

Headline Expenditure Projections

- Pharmaceuticals: EUR4.95bn (USD5.44bn) in 2015 to EUR4.67bn (USD5.00bn) in 2015, -5.5% inlocal currency terms and -8.1% in US dollar terms.

- Healthcare: EUR15.38bn (USD16.92bn) in 2015 to EUR15.22bn (USD16.29bn) in 2016, -1.0% in localcurrency terms and -3.7% in US dollar terms.

Table Of Contents

Greece Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Greece 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Greece 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Greece 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Greece 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Greece 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Greece 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Greece 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Greece 2012-2020) 26
OTC Drug Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Greece 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Greece 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Greece 2014-2020) 31
Industry Risk/Reward Index 32
Central And Eastern Europe Risk/Reward Index - Q3 2016 32
Greece Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 41
Pricing Regime 42
Reimbursement Regime 43
Market Overview 46
Healthcare Sector 46
Table: Healthcare Resources (Greece 2010-2015) 50
Table: Healthcare Personnel (Greece 2010-2015) 50
Table: Healthcare Activity (Greece 2010-2015) 51
Healthcare Insurance 51
Research and Development 52
Clinical Trials 52
Epidemiology 53
Competitive Landscape 56
Research-Based Industry 56
Table: Multinational Market Activity 58
Pharmaceutical Distribution 59
Pharmaceutical Retail Sector 60
Company Profile 61
Elpen 61
Genesis Pharma 63
Kleva 65
Lavipharm 66
Pharmathen 68
Vianex 71
Demographic Data 73
Demographic Forecast 73
Table: Population Headline Indicators (Greece 1990-2025) 74
Table: Key Population Ratios (Greece 1990-2025) 74
Table: Urban/Rural Population and Life Expectancy (Greece 1990-2025) 75
Table: Population By Age Group (Greece 1990-2025) 75
Table: Population By Age Group % (Greece 1990-2025) 76
Glossary 78
Methodology 80
Pharmaceutical Expenditure Forecast Model 80
Healthcare Expenditure Forecast Model 80
Notes On Methodology 81
Risk/Reward Index Methodology 82
Index Overview 83
Table: Pharmaceutical Risk/Reward Index Indicators 83
Indicator Weightings 84

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.